Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Latour´s CFO will leave during 2025

Anders Mörck, CFO of Investment AB Latour, has announced that he will leave his role as CFO during 2025, aiming for April 30, 2025. Anders has held his position as CFO since 2008. ”I have concluded that I am ready for the next phase in my life, and hence I am not leaving for another assignment outside Latour. I have had the best job I ever could wish for, and I will leave fantastic colleagues and companies that I love. I hope somehow to have the opportunity to stay connected going forward”, says Anders Mörck. ”I would like to thank Anders for his significant efforts during all these

AMENDMENT OF FINANCIAL CALENDAR (2024-2025)

PRESS RELEASE30 August 2024, at 14:00 – Stockholm.Arte Collectum II AB (publ)www.artecollectum.comArte Collectum II AB (publ), reg. no. 559479-2722 (the ‘Fund’), hereby adjusts its financial calendar for the period 2024-2025. The Fund's financial calendar is presented below.2025-02-28: Publication of Financial Statement 20242025-04-25: Publication of Annual Report 20242025-05-30: Annual General Meeting 20252025-08-22: Publication of Interim Report 2025 * * *  For further information, please contact:Jonas Höglund, Chief Executive OfficerTelephone: +46 733 76 67 55

EQT INFRASTRUCTURE VI, THROUGH OTELLO BIDCO AB, SHORTENS THE ACCEPTANCE PERIOD FOR THE RECOMMENDED PUBLIC OFFER TO THE SHAREHOLDERS OF OX2 AB (PUBL) AND ANNOUNCES ADDITIONAL SHARE ACQUISITIONS

This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled “Important information” at the end of this announcement and in

SSAB’s own steels feature prominently in Raahe steel mill's new research and office building

The new combined research center and  office at SSAB’s Raahe steel mill was completed this spring and will be phased in during the fall. As much SSAB steel as possible has been used for the construction of the building, which also serves as a showcase for the company’s own products. The color combination of gray and rusty brown is typical of the factory site. Photo: Nick Tulinen The new building is located by the road leading to the factory. The research center will carry out research into both raw materials and the finished products produced at the factory, and will help to

Notification of Major Holdings in Catena Media plc

Catena Media plc (the "Company") hereby announces that it has on 28 August received a notification from Nordea Bank Abp, with registered office in Helsinki, Finland. The notification is with regards to an acquisition of shares and voting rights in the Company (the "Notification") made by Nordea Bank Abp. The Notification indicates that Nordea Bank Abp, as of 21 August 2024, holds 5.2% of the shares and voting rights in the Company. The entire notification is available at the Company's website on the following link: https://www.catenamedia.com/corporate-governance/major-holdings/

Top 10 Online Casinos in Europe: Summer 2024 Overview by CasinoRank

August 30, 2024 – As summer draws to a close, it’s time to look back and evaluate the top performers in the online casino market. CasinoRank, a leading global network of casino review websites dedicated to various aspects of iGaming, has compiled a list of the top 10 online casinos in Europe for the summer of 2024. This ranking is based on a detailed analysis of each casino’s popularity, game selection, payment methods, user experience, and overall reputation.The CasinoRank team used a combination of quantitative and qualitative indicators to evaluate each casino’s standing. Key metrics

Skanska Financial Services AB (publ)’s six-month report, January–June 2024, published

Skanska Financial Services AB (publ)’s six-month report for January–June 2024 (in Swedish) is attached to this press release and is available on the company’s website, https://group.skanska.com/investors/funding/skanska-financial-services-ab/   This is information that Skanska Financial Services AB (publ) is obliged to make public pursuant to Nasdaq Stockholm’s Rule Book for Issuers of Fixed Income Instruments. The information was submitted for publication, through the agency of the Senior Vice President Investor Relations set out below, at 1:00 pm CEST on August 30, 2024.

Elkem ASA – Approval of the intra-group merger with Elkem Testvirksomhet AS

Oslo, 30 August 2024 Reference is made to Elkem ASA’s (“Elkem”) announcement on 28 June 2024 regarding the merger between Elkem and Elkem Testvirksomhet AS. The board of directors of Elkem and Elkem Testvirksomhet AS have today approved the merger. The decision to approve the merger will be registered with the Norwegian Register of Business Enterprises and is scheduled to take place by the end of 2024. The merger is expected to be implemented upon expiration of the statutory six-week creditor notice period. This information is subject to the disclosure requirements pursuant to

Invitation to Investor Webinar on Tues 3 Sept 2024 at 16:00 CEST: H1 2024 report and new Chief Commercial Officer

Copenhagen, Denmark, 30. August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Sign-up here  At the webinar, Brain+ will present its recently released H1 2024 report, including upcoming milestones and commercial outlook for the company in the UK. The webinar is an opportunity to meet new Chief Commercial Officer Devika Wood and will also be hosted by CEO and founder Kim Baden-Kristensen and CFO Hanne Vissing Leth.Half-year 2024 report & presentation by new Chief Commercial Officer 3 Sept 2024 at 16:00 CEST – A

DexTech Medical AB, Year-end report July 1, 2023 - June 30, 2024

Summary of year-end report Fourth quarter (2024-04-01 – 2024-06-30) · Net sales amounted to SEK 0.0 million (0.0) · Operating profit amounted to SEK -1.6 million (-1.3) · Earnings per share* SEK -0.07 (-0.06) Full year (2023-07-01 – 2024-06-30) · Net sales amounted to SEK 0.0 million (0.0) · Operating profit amounted to SEK -5.5 million (-4.9) · Earnings per share* SEK -0.25 (-0.25) · Cash and cash equivalents at the end of the financial year amounted to SEK 19.0 (25.2) million * Before and after dilution. Earnings per share: Profit for the period divided

Vår Energi completes sale of Norne area assets and increases its interest in the Ringhorne East Unit

Sandnes, Norway 30 August 2024: Vår Energi ASA (OSE: VAR) completes the sale of its Norne area field interests to DNO Norge AS for a fixed after-tax consideration of USD 51 million. The Norne area is located in the Norwegian Sea and the transaction include interests in the Norne (6.9%), Urd (11.5%), Skuld (11.5%) and Marulk (20%) fields and the Verdande (10.49%) development project. As part of the transaction DNO Norge has assigned to Vår Energi their 22.62% interest in the Ringhorne East unit, taking Vår Energi’s interest to 92.6%. The transaction with DNO Norge is in line with Vår

RESQUNIT AB (PUBL) Announces Bankruptcy Filing for Subsidiary RESQUNIT AS, Operations Continue in the parent company

Stockholm, August 30, 2024, 12:18 CET — RESQUNIT AB (PUBL) (the Company) (Nasdaq First North: RESQ) announces that the board of its wholly-owned subsidiary, RESQUNIT AS (the Subsidiary), has decided to file for bankruptcy with the Sør-Rogaland District Court in Norway. This decision follows a prolonged period of financial difficulty for the Subsidiary, driven by challenges in market adoption and adverse economic conditions.Background on the Subsidiary and reason for bankruptcy Resqunit AS, founded in 2017, focused on developing and marketing innovative solutions for the fishing industry,

Cambio receives MDR certification for EHR-system and clinical decision support

Cambio's electronic health record system Cosmic and their solution for clinical decision support (CDS) have now been registered and certified according to MDR, the Medical Device Regulation. This means that the products are approved and CE-marked in accordance with the EU regulation on medical devices, which ensures the safety and performance of medical equipment. "The MDR certification is an important milestone for us as a company, and I am very proud of the work we have done together at Cambio. The certification is proof that those who use our products can trust that they meet the

Nordea Kredit Realkreditaktieselskab – Interim Report January-June 2024 Company announcement no 77

Nordea Kredit Realkreditaktieselskab –  Interim Report January-June 2024   Company announcement no 77   Nordea Kredit Realkreditaktieselskab today presented the attached Interim Report January-June 2024.               For further information:   External Communication DK, +45 70 80 11 62   Nordea Kredit Realkreditaktieselskab Grønjordsvej 10 PO Box 850 DK-2300 København S   nordeakredit.dk

ABAX Group AS Q2 Interim Report 2024: Steady growth amidst economic challenges

ABAX Group AS, a European leader in telematics and Smart Mobility, today announced its financial results for the second quarter. The company reported revenue of 205.7 million NOK, a 1% increase from 203.2 million NOK in the same period last year, reflecting resilience amidst ongoing macroeconomic challenges.Key Financial Highlights: · Total Revenue: 205.7 million NOK, up from 203.2 million NOK, with a year-over-year growth of 1%. · Revenue Growth Outside Sweden: Strong performance with a 7% increase year-over-year, despite Sweden's market being impacted by macroeconomic headwinds,

Read original

Trial Run of Final Disposal started today in Olkiluoto

The final disposal of spent nuclear fuel will be tested without actual spent fuel during the upcoming months. The equipment and systems of the final disposal facility will be tested together for the first time in accordance with planned processes during the Trial Run stage that started today. The purpose of the Trial Run is to verify safe final disposal before the start of the actual final disposal operation.In Finland, the power companies have decided to deposit the spent nuclear fuel produced by the nuclear power plants deep in the stable bedrock for final disposal. Prior to final

Voi promotes safer micromobility in Belgium

Credit: Voi Europe’s leading micromobility operator, Voi, is benefitting from the expertise of Vias Institute, a road safety and mobility knowledge centre, to promote safe e-scooter and e-bike riding in Belgium. To enhance safe riding, Vias supported the development of a ten-question challenge for people to take when completing Voi’s online traffic school, RideSafe Academy. The quiz is tailored to common situations and challenges faced by riders in Belgium - and is available in Dutch, English and French. It is one of the many actions that can support safe riding. It

First Delivery of Rear-view Cameras Completed

Today, the first shipment of 25 cameras is being sent to a government client. However, the high pace at the assembly plant in Karlsborg continues.During the spring, Railway Metrics and Dynamics received several orders for both PMUs and rearview cameras. This, along with advanced discussions on further orders, led to the decision to begin series production. A total of 120 PMUs and 100 rearview cameras were to be manufactured — and now, 25 of the cameras have been delivered to a major government client. – The interest in our rearview cameras has been significant, and series production

First day of trading in warrants of series TO1

Eevia Health Plc ("Eevia" or the "Company") carried out a rights issue of shares and warrants (the “Rights Issue”) in June/July 2024. The first day of trading in warrants of series TO1 (the "Warrants") issued as part of the Rights Issue on Spotlight Stock Market is September 4, 2024. The last day of trading in the Warrants is August 26, 2025. The Warrants will be traded under the short name (ticker) EEVIA TO 1.Through the Rights Issue, 7,160,396 Warrants of series TO1 have been issued.   Each warrant of series TO1 entitles the holder to subscribe for one (1) new share in the Company

Change in the number of shares and votes in BioGaia AB (publ)

The number of shares and votes in BioGaia AB (publ) increased in August due to the exercise of some warrants issued under the BioGaia incentive program 2021/2024 for subscription of shares. Through this subscription, the number of Class B shares and votes in BioGaia increased by 140,000 and the share capital increased by SEK 28,000. As of August 30, 2024, the total number of shares in BioGaia amounts to 101,157,310 of which 3,703,340 are Class A shares with ten votes each and 97,453,970 are Class B shares with one vote each, totaling 134,487,370 votes. Additionally, the share capital

Conversion of shares in NCC AB, August 2024

According to NCC’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During August 2024, 27,360 Series A shares were converted to Series B shares at the request of shareholders, following which the total number of voting rights in the company amounts to 160,939,959. The total number of registered shares in the company amount to 99,760,956 of which 6,797,667 are Series A and 92,963,289 are Series B. NCC holds 1,968,589 Series B shares in treasury.

Gothenburg and AstraZeneca deepen ties to strengthen life science sector

Gothenburg is to get its first regional business strategy for life science. The initiative comes from Business Region Göteborg and AstraZeneca, which have entered a strategic collaboration. The aim is to further strengthen the entire life science sector and create jobs and growth in the region.AstraZeneca is by far the largest life science company in Sweden. The company has its production in Södertälje, while research and development are concentrated in Gothenburg.  The Gothenburg region has one of the Nordic region's most important health innovation clusters, largely thanks to

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top